Literature DB >> 14691349

Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis.

Jolanta Małyszko1, Jacek S Małyszko, Michał Myśliwiec.   

Abstract

AIM: In chronic renal failure in dialyzed patients vascular damage is frequently observed and it is probable that disturbances in fibrinolytic activity and endothelial dysfunction may play a role in vascular complications such as stroke or ischemic heart disease. There have been a few data concerning hemostasis in chronic renal failure. Since hemostatic disturbances in nephrotic syndrome mimick those observed in patients maintained on chronic ambulatory peritoneal dialyses (CAPD), the aim of the study was to assess adhesion molecules (P-selectin, E-selectin, ICAM, VCAM and markers of endothelial cell injury), von Willebrand factor, thrombomodulin, and TFPI (tissue factor pathway inhibitor) in CAPD patients as well as in subjects with chronic renal failure (CRF) treated conservatively.
METHODS: The studies were performed on 23 CAPD patients, 24 patients with nephrotic syndrome and 24 sex- and age-matched healthy volunteers. TFPI total, full length, truncated, von Willebrand factor, trombomodulin, P-selectin, E-selectin, ICAM, VCAM and vascular endothelial growth factor (VEGF) and its receptor sFlt3 were assayed using commercially available kits. We evaluated also thrombin activity (thrombin-antithrombin complexes (TAT), prothrombin fragments 1 and 2) and the degree of plasmin generation.
RESULTS: In CAPD and CRF patients, concentrations of the adhesion molecules P-selectin, E-selectin, ICAM and VCAM were significantly higher when compared to the control group. Concentrations of total, free and truncated TFPI were significantly higher in CAPD and CRF patients when compared to the healthy volunteers. Concentrations of 'classical' markers of endothelial cell injury, von Willebrand factor and thrombomodulin, were significantly higher in CAPD and CRF patients when compared to the control group. In CAPD patients, VCAM and thrombomodulin were significantly elevated when compared to the CRF patients.
CONCLUSIONS: The elevated levels of adhesion molecules in CAPD patients probably reflect inadequate clearance as well as enhanced synthesis/release. They may also indicate endothelial cell injury as well as elevated levels of von Willebrand factor and trombomodulin and increased ICAM and VCAM in CAPD patients. Our studies indicate that in renal failure patients, particularly on CAPD, there is evidence of endothelial cell injury and a high degree of hypercoagulation relative to healthy subjects. It may lead to fibrin deposition in the vascular wall, thrombus formation, and development and progression of atherosclerosis with its complications. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14691349     DOI: 10.1159/000075810

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  10 in total

1.  Tissue factor pathway inhibitor in paediatric patients with nephrotic syndrome.

Authors:  Farida Ahmed Farid; Ahmed Abdullah Mohammed; Hanaa Mohammed Afifi; Rania Saleh Beltagi
Journal:  SAJCH       Date:  2011-12

2.  Soluble VCAM-1 and E-selectin in PD patients: the additive value of the free diffusion coefficient in the assessment of local peritoneal production.

Authors:  Deirisa Lopes Barreto; Annemieke M Coester; Annemiek Heijne; Dirk R de Waart; Frans J Hoek; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2015 Jan-Feb       Impact factor: 1.756

3.  Protein Z and natural anticoagulants in children on peritoneal dialysis and hemodialysis.

Authors:  Kenan Bek; Ozan Ozkaya; Tunç Fişgin; Yüksel Aliyazicioğlu; M Sükrü Paksu; Tolga Ozgen; Davut Albayrak; Kemal Baysal
Journal:  Pediatr Nephrol       Date:  2006-11-24       Impact factor: 3.714

Review 4.  Intimal Hyperplasia and Arteriovenous Fistula Failure: Looking Beyond Size Differences.

Authors:  Roberto I Vazquez-Padron; Juan C Duque; Marwan Tabbara; Loay H Salman; Laisel Martinez
Journal:  Kidney360       Date:  2021-08

5.  Coagulation factors as biological risk markers of endothelial dysfunction. Association with the thrombotic episodes of chronic hemodialysis patients.

Authors:  A Sioulis; P Malindretos; A Makedou; P Makris; D Grekas
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

Review 6.  Thrombosis in the uremic milieu--emerging role of "thrombolome".

Authors:  Moshe Shashar; Jean Francis; Vipul Chitalia
Journal:  Semin Dial       Date:  2014-06-24       Impact factor: 3.455

7.  Low-grade risk of hypercoagulable state in patients suffering from diabetes mellitus type 2.

Authors:  Barbara Ruszkowska-Ciastek; Alina Sokup; Tomasz Wernik; Piotr Rhone; Krzysztof Góralczyk; Kornel Bielawski; Agata Fijałkowska; Aleksandra Nowakowska; Elżbieta Rhone; Danuta Rość
Journal:  J Zhejiang Univ Sci B       Date:  2015-09       Impact factor: 3.066

8.  Primary patency rate of native AV fistula: long term follow up.

Authors:  Kazemzadeh Gh; Modaghegh Mhs; Ravari H; Daliri M; Hoseini L; Nateghi M
Journal:  Int J Clin Exp Med       Date:  2012-04-06

Review 9.  The vascular endothelium and human diseases.

Authors:  Peramaiyan Rajendran; Thamaraiselvan Rengarajan; Jayakumar Thangavel; Yutaka Nishigaki; Dhanapal Sakthisekaran; Gautam Sethi; Ikuo Nishigaki
Journal:  Int J Biol Sci       Date:  2013-11-09       Impact factor: 6.580

10.  Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by (19)F NMR of VCAM-1 targeted nanobeacons.

Authors:  Richard Southworth; Megan Kaneda; Junjie Chen; Lei Zhang; Huiying Zhang; Xiaoxia Yang; Reza Razavi; Gregory Lanza; Samuel A Wickline
Journal:  Nanomedicine       Date:  2009-01-19       Impact factor: 5.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.